A decision-first checklist for your next clinician visit: prioritize actionable cardiometabolic tests, add symptom-led testing, and avoid expensive panels without a follow-up plan.
Useful longevity blood tests identify a risk or deficiency you can act on. A lipid panel and appropriate diabetes screening often belong ahead of expensive biological-age or hormone bundles. The right list depends on your age, symptoms, medical history, family history, and treatment decisions.
This article is a prioritization checklist, not a universal laboratory order. For a longer catalog of markers, see our complete blood-test panel explainer. More results do not necessarily produce better prevention.
Before ordering a test, ask: “What would we do differently if the result is high, low, or normal?” If no one can answer, the test may be interesting without being useful.
Testing also misses important information. Blood pressure, smoking status, physical activity, sleep, medication use, and family history help determine cardiovascular risk even though they are not all blood biomarkers. Keep routine preventive care and appropriate cancer screening in the plan.
Lipid panel: total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides help inform risk assessment. An LDL result should be interpreted alongside your overall risk and history rather than judged against an influencer's preferred target.
HbA1c or fasting plasma glucose: these can help screen for prediabetes or diabetes when appropriate. The USPSTF recommendation covers adults aged 35–70 with overweight or obesity; other risk factors and guidelines can support testing outside that group.
ApoB: it can help clarify the number of atherogenic particles when a clinician believes the standard lipid picture is insufficient, particularly with triglyceride elevation or discordant results. It is not simply a replacement for every part of a lipid panel.
Lipoprotein(a), or Lp(a): a largely inherited cardiovascular risk factor. Discuss testing, especially with premature cardiovascular disease in your family. The American Heart Association overview explains why it adds information that a standard lipid panel may miss.
A blood count, kidney or liver tests, thyroid testing, iron studies, B12, or vitamin D may be useful in specific situations. For example, unexplained fatigue, anemia, dietary restriction, or monitoring a medicine gives these tests a concrete purpose.
That does not mean all asymptomatic people need all of them every year. A low result should lead to a discussion about its cause, not an automatic supplement purchase. Iron deficiency can require investigation, and abnormal kidney results deserve interpretation before adding supplements.
Broad hormone panels without symptoms, serial inflammatory markers without an action plan, and direct-to-consumer biological-age scores can generate costs and anxiety. A number predicting risk does not necessarily show which intervention will improve your outcome.
Some tests fluctuate with infection, exercise, sleep, recent meals, or medication changes. Repeating every marker frequently can reveal noise rather than a meaningful trend.
1. Bring earlier results, current prescriptions, and your supplement list.
2. Ask which tests require fasting; HbA1c does not, and many lipid assessments can be performed without fasting.
3. Do not stop prescribed medication to “clean up” results unless your clinician instructs you to.
4. Agree on when to repeat a test and what change would justify action.
After results arrive, review them together. Do not diagnose yourself from an isolated flagged value or from an online longevity “optimal range.”
How often should I test? There is no universal annual longevity panel. Frequency depends on baseline risk, symptoms, prior findings, and treatment monitoring.
Can a home test replace medical care? Home collection may be convenient for selected validated tests, but interpretation and follow-up still matter. Do not use a consumer kit to delay assessment of symptoms.
Can blood tests tell me how long I will live? Not precisely. They can help identify modifiable risks, but they are not a personal lifespan forecast.
The best panel is one you can explain and act on. Ask your clinician to prioritize actionable risk, then add targeted tests rather than purchasing the largest bundle available.